Mortality Risk of Hypnotics: Strengths and Limits of Evidence.

Mortality Risk of Hypnotics: Strengths and Limits of Evidence.

Item
http://www.wikidata.org/entity/Q38631980
Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefitPredicting Future Self-Reported Motor Vehicle Collisions in Subjects with Primary Open-Angle Glaucoma Using the Penalized Support Vector Machine MethodThe Quest for Mindful Sleep: A Critical Synthesis of the Impact of Mindfulness-Based Interventions for Insomnia.What do hypnotics cost hospitals and healthcare?Zolpidem Administration and Risk of Hepatocellular Carcinoma: A Case-Control Study in Taiwan.Patterns of zolpidem use among Iraq and Afghanistan veterans: A retrospective cohort analysis.Does a Consumer-Targeted Deprescribing Intervention Compromise Patient-Healthcare Provider Trust?Common Drug Side Effects and Drug-Drug Interactions in Elderly Adults in Primary CareExercise can improve sleep quality: a systematic review and meta-analysis
P2860

Mortality Risk of Hypnotics: Strengths and Limits of Evidence.

Item
http://www.wikidata.org/entity/Q38631980
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Mortality Risk of Hypnotics: Strengths and Limits of Evidence.
@en
type
label
Mortality Risk of Hypnotics: Strengths and Limits of Evidence.
@en
prefLabel
Mortality Risk of Hypnotics: Strengths and Limits of Evidence.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P6179
P698
P356
P1433
P1476
Mortality Risk of Hypnotics: Strengths and Limits of Evidence.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P6179
P698